Your browser doesn't support javascript.
loading
PROMPT: Prospective Meta-analysis for Pessary Trials Study Protocol.
Thom, Elizabeth A; Saade, George R; Askie, Lisa M; Ugwu, Lynda G; Mol, Ben W J; Vayssiere, Christophe; Norman, Jane E; Pajkrt, Eva; Clifton, Rebecca G; Biggio, Joseph R; Arnaud, Catherine; Berghella, Vincenzo; Canino, Maria G; Carreras, Elena; Dugoff, Lorraine; Hoffman, Matthew K; Pacagnella, Rodolfo C; Reddy, Uma M; Saccone, Gabriele; Hooft, Janneke van 't; Dang, Vinh Q.
  • Thom EA; The George Washington University Biostatistics Center, Washington, District of Columbia.
  • Saade GR; Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas.
  • Askie LM; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Ugwu LG; The George Washington University Biostatistics Center, Washington, District of Columbia.
  • Mol BWJ; Department of Obstetrics and Gynecology, Monash University, Monash, Australia.
  • Vayssiere C; Department of Obstetrics and Gynecology, Toulouse III University, Toulouse, France.
  • Norman JE; University of Nottingham, Nottingham, United Kingdom.
  • Pajkrt E; Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The Netherlands.
  • Clifton RG; The George Washington University Biostatistics Center, Washington, District of Columbia.
  • Biggio JR; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Arnaud C; Department of Obstetrics and Gynecology, Toulouse III University, Toulouse, France.
  • Berghella V; Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Canino MG; Department of Obstetrics and Gynaecology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Carreras E; Department of Obstetrics and Gynaecology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Dugoff L; Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hoffman MK; Department of Obstetrics and Gynecology, Columbia University, New York, New York.
  • Pacagnella RC; Department of Obstetrics and Gynecology, State University of Campinas-UNICAMP, São Paulo, Brazil.
  • Reddy UM; Division of Extramural Research Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
  • Saccone G; Department of Obstetrics and Gynecology, University of Naples Federico II, Naples, Italy.
  • Hooft JV'; Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The Netherlands.
  • Dang VQ; Department of Obstetrics and Gynecology, My Duc Hospital, Ho Chi Minh City, Viet Nam.
Am J Perinatol ; 2023 Jul 10.
Article en En | MEDLINE | ID: mdl-37429323
ABSTRACT

OBJECTIVE:

Preterm birth, defined as birth before 37 weeks of gestation, is a leading cause of perinatal and infant mortality throughout the world. Preterm birth is also associated with long-term neurological disabilities and other significant health issues in children. A short cervix in the second trimester has been noted to be one of the strongest predictors of subsequent spontaneous preterm birth in both singleton and multiple pregnancies. Some studies have shown that cervical support in the form of an Arabin pessary lowers the risk of preterm birth in women with a singleton gestation and short cervical length; however, other studies have conflicting results. Our objective was to form an international collaborative of planned or ongoing randomized trials of pessary in singleton and twin gestations with a short cervix. STUDY

DESIGN:

In November 2014, an international group of investigators, who had initiated or were planning randomized trials of pessary for pregnant people with a short cervix and singleton or twin gestation to prevent preterm birth, formed a collaboration to plan a prospective individual patient data (IPD) meta-analysis of randomized trials (PROspective Meta-analysis of Pessary Trials [PROMPT]). The PROMPT investigators agreed on meta-analysis IPD hypotheses for singletons and twins, eligibility criteria, and a set of core baseline and outcome measures. The primary outcome is a composite of fetal death or preterm delivery before 32 weeks' gestation. Secondary outcomes include maternal and neonatal morbidities. The PROMPT protocol may be viewed as a written agreement among the study investigators who make up the PROMPT consortium (PROSPERO ID# CRD42018067740).

RESULTS:

Results will be published in phases as the individual participating studies are concluded and published. Results of the first phase of singleton and twin pessary trials are expected to be available in late 2022. Updates are planned as participating trials are completed and published. KEY POINTS · Short cervical length predicts preterm birth.. · Results of prior cervical pessary trials are mixed.. · Meta-analysis of pessary trials protocol..

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Año: 2023 Tipo del documento: Article